NRSNW NEUROSENSE THERAPEUTICS LTD
Follow*W EXP 11/10/202 (warrant or right), issuer CIK 1875091
3 managers (3 13F filers) reported a position in NRSNW shares at 2026-06-30, 164,650 shares in all. 0 filers opened a position and 0 filers sold out during the quarter.
- Managers
- 3
- 13F filers
- 3
- New
- 0
- Added
- 0
- Reduced
- 1
- Sold out
- 0
- Shares held by filers
- 164,650
Shares held by filers adds up every 13F filer's report, so a share reported by a parent and by its subsidiary counts twice (H9). Managers counts each filer group once.
13D and 13G filers
No 13D or 13G on this security in the data. Structured 13D/G data starts 2024-12-18.
Insider trades
No Form 4 transaction on this security in the data.
13F holders, Q2 2026
Filers in the available 13F reports with a share position at 2026-06-30, filer groups collapsed to one row (method), largest first. Options and principal amounts are left out. A group row states no % of portfolio, since each member reports its own portfolio: the members' percents are listed under it. A value about 1,000 times or 1/1,000 of the price other filers imply is shown as filed but neither ranks the row nor enters a sum.
| Holder | Shares | Value | % of portfolio | Change | Source |
|---|---|---|---|---|---|
| Empery Asset Management, LP | 100,402 | $6.33K | 0.01% | 0 | 13F-HRTimeline |
| Clear Street Group Inc.in group Clear Street Group Inc. | 63,085 | $3.97K | <0.01% | -300 | 13F-HRTimelineGroup |
| UBS Group AGin group UBS Group AG | 1,163 | $73 | <0.01% | 0 | 13F-HRTimelineGroup |